TL;DR: A 2026 protocol in PLOS One describes a 90-person pilot randomized controlled trial that will test whether virtual reality mindfulness can reduce depression, anxiety, stress, and caregiver burden in family caregivers of people with dementia. Key Findings 90-caregiver pilot: The planned sample includes 90 caregivers of community-dwelling people with dementia in Hong Kong. Three …
TL;DR: A 2026 npj Parkinson’s Disease study used brain transcriptome data and genome-scale metabolic modeling to predict Parkinson’s metabolite biomarkers, including dopamine-related changes, and separated 104 postmortem samples into three metabolic clusters. Key Findings Metabolic model: The study used TAMBOOR, a transcriptome-based metabolic modeling algorithm, to predict metabolite oversecretion and undersecretion. Brain tissue data: The …
TL;DR: A 2026 population-based study in The Canadian Journal of Psychiatry found that early-life adversity scores were linked to higher group-level mental health risk but performed poorly for identifying which Canadian adults had anxiety, mood disorders, substance use disorders, or suicidality. Key Findings 7,608 Canadian adults: Researchers analyzed nationally representative 2022 survey data collected during …
TL;DR: A 2026 systematic review and meta-analysis in Acta Neuropsychiatrica found no clear evidence that parenteral clomipramine is better than oral clomipramine for depression or obsessive-compulsive disorder, with low or very low certainty across the main randomized-trial evidence. Key Findings 4,973 publications screened: The review identified 14 randomized controlled trials relevant to parenteral clomipramine in …
TL;DR: A 2026 cross-sectional study in Psychiatry Research surveyed 558 Palestinian refugees displaced to Egypt after the 2023 Gaza war and used Bayesian network analysis to map their psychological symptoms; suicidal ideation emerged as the central hub for both men and women, with secondary core symptoms differing by gender (loss of energy in men, psychomotor …
TL;DR: A 2026 secondary randomized-trial analysis in Journal of Medical Internet Research found that both online MBCT formats reduced psychological distress and improved well-being through 9 months, while people with fewer psychological resources appeared to gain larger benefits. Key Findings Study type: a long-term follow-up of two online mindfulness-based cognitive therapy formats for people with …
TL;DR: A 2026 study in Personality and Individual Differences found that people higher in neuroticism reported more problem- and uncertainty-focused thoughts during blank-screen rest periods, which tracked with more unpleasant feelings. Key Findings Neuroticism was tested during idle thought: researchers used a blank-screen paradigm to sample what participants thought about when they had no task …
TL;DR: A 2026 preprint neurosurgery neuroplasticity study in medRxiv found that language-targeted prehabilitation selectively changed language-network topography, while language and cognitive performance were preserved after the intervention. Key Findings Study type: a prehabilitation study using neuromodulation, language training, task-based functional MRI (fMRI), and neuropsychological testing. People studied: 26 patients with operable brain tumors affecting language …
TL;DR: A 2026 study in Drug Design, Development and Therapy validated liquid chromatography-tandem mass spectrometry (LC-MS/MS), a high-specificity lab method, to screen serum for 77 neuropsychiatric drugs and then applied it to 1,021 clinical specimens over 3 years. Key Findings 77 drugs screened: Researchers developed a serum LC-MS/MS method for simultaneous qualitative identification of neuropsychiatric …
TL;DR: A 2026 human laboratory study in Drug and Alcohol Dependence Reports found that naltrexone/bupropion did not change whether people with binge-eating disorder started eating preferred snacks, but it reduced how many calories they ate once they began. Key Findings Naltrexone/bupropion trial included 50 adults: Participants came from a randomized trial of naltrexone/bupropion, including 23 …
